Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/sage/integrated-testing-strategies-for-use-in-the-eu-reach-system-jA8UiLRkFN
References (16)
-
A. Warmington (2002)
Rhodia looks to the next generationSpeciality chemicals, 22
-
S. Jeram, J. Sintes, Marlies Halder, J. Fentanes, B. Sokull-Kluettgen, Thomas Hutchinson (2005)
A strategy to reduce the use of fish in acute ecotoxicity testing of new chemical substances notified in the European Union.Regulatory toxicology and pharmacology : RTP, 42 2
-
R. Combes (2005)
Assessing risk to humans from chemical exposure by using non-animal test data.Toxicology in vitro : an international journal published in association with BIBRA, 19 7
-
R. Dashwood, R. Combes (1987)
The use of in vivo-like concentrations of chemicals for validation of in vitro short-term genotoxicity assays--an in vivo equivalent dose concept.Mutagenesis, 2 4
-
G. Persoone, B. Maršálek, I. Blinova, A. Törökné, D. Zarina, L. Manusadžianas, G. Nałęcz-Jawecki, Lucica Tofan, N. Stepanova, Lívia Tóthová, B. Kolar (2003)
A practical and user‐friendly toxicity classification system with microbiotests for natural waters and wastewatersEnvironmental Toxicology, 18
-
W. Hal, B. Blaauboer, H. Barentsen, M. Hoitink, I. Meerts, J. Hoeven (2005)
An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing.Regulatory toxicology and pharmacology : RTP, 42 3
-
T. Höfer, I. Gerner, U. Gundert-Remy, M. Liebsch, A. Schulte, H. Spielmann, R. Vogel, K. Wettig (2004)
Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulationArchives of Toxicology, 78
-
R. Dashwood, R. Combes, J. Ashby (1987)
Comparison of the activation of a carcinogen/ non-carcinogen pair of monoazo dyes using in vitro and in vivo genotoxicity assays: The use of an ‘in vivo equivalent dose concept’Mutation Research, 181
-
N. Bhogal, C. Grindon, R. Combes, M. Balls (2005)
Toxicity testing: creating a revolution based on new technologies.Trends in biotechnology, 23 6
-
O. Gessner (1944)
Tödliche Vergiftung durch Früchte des Ligusterstrauches (Ligustrum vulgare L.) bei einem 5-jährigen KindeFühner-Wieland's Sammlung von Vergiftungsfällen, 13
-
L. Koch, N. Ash́ford (2006)
Rethinking the Role of Information in Chemicals Policy: Implications for TSCA and REACHJournal of Cleaner Production, 14
-
C. Eskes (2005)
Alternative (non-Animal) Methods for Cosmetics Testing : Current Status and Future Prospects. A Report Prepared in the Context of the 7th Amendment to the Cosmetics Directive for Establishing the Timetable for Phasing Out Animal Testing, 33
-
R. Fielder, C. Atterwill, D. Anderson, A. Boobis, P. Botham, M. Chamberlain, R. Combes, P. Duffy, R.W. Lewis, C. Lumley, I. Kimber, D.R. Newall (1997)
BTS working party report on in vitro toxicologyHuman and Experimental Toxicology, 16
-
M. Cronin, J. Jaworska, John Walker, M. Comber, C. Watts, Andrew Worth (2003)
Use of QSARs in international decision-making frameworks to predict health effects of chemical substances.Environmental Health Perspectives, 111
-
Katinka Jagt, S. Munn, J. Tørsløv, Jack Bruijn (2004)
Alternative Approaches Can Reduce the Use of Test Animals under REACH. -
Joanna Burger (2003)
Differing perspectives on the use of scientific evidence and the precautionary principlePure and Applied Chemistry, 75
- Publisher
- SAGE
- Copyright
- © 2006 Fund for the Replacement of Animals in Medical Experiments
- ISSN
- 0261-1929
- eISSN
- 2632-3559
- DOI
- 10.1177/026119290603400402
- Publisher site
- See Article on Publisher Site
Abstract
Integrated testing strategies have been proposed to facilitate the process of chemicals risk assessment to fulfil the requirements of the proposed EU REACH system. Here, we present individual, decision-tree style, strategies for the eleven major toxicity endpoints of the REACH system, including human health effects and ecotoxicity. These strategies make maximum use of non-animal approaches to hazard identification, before resorting to traditional animal test methods. Each scheme: a) comprises a mixture of validated and non-validated assays (distinguished in the schemes); and b) decision points at key stages to allow the cessation of further testing, should it be possible to use the available information to classify and label and/or undertake risk assessment. The rationale and scientific justification for each of the schemes, with respect to the validation status of the tests involved and their individual advantages and limitations, will be discussed in detail in a series of future publications.
Journal
Alternatives to Laboratory Animals – SAGE
Published: Aug 1, 2006